Hainan Huluwa Pharmaceutical Group Co Ltd
605199
Company Profile
Business description
Hainan Huluwa Pharmaceutical Group Co Ltd is engaged in production and sales of Chinese patent medicines and chemical drugs. The company produces medicines for children's respiratory and digestive systems. Its products include star products, calabash, gourd dad, and gourd mom.
Contact
No. 8, Yaogu 4th Road, Phase II
Yaogu Industrial Park
Haikou National High-tech Zone
Hainan Province
Haikou570300
CHNT: +86 8986868976
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
2,103
Stocks News & Analysis
stocks
The ‘other’ AI chip behemoth that might just be getting started
The magnitude of growth at Broadcom continues to astound us.
stocks
Why ANZ changes aren’t just about cutting costs
The banking major needs to prevent key product offerings from falling further behind the competition.
stocks
Strong finish to the year for overvalued ASX share
A great fiscal 2025 but investors are ahead of themselves.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 9,095.20 | 28.80 | 0.32% |
CAC 40 | 7,800.25 | 50.86 | 0.66% |
DAX 40 | 23,827.02 | 108.57 | 0.46% |
Dow JONES (US) | 45,711.34 | 196.39 | 0.43% |
FTSE 100 | 9,257.57 | 15.04 | 0.16% |
HKSE | 26,196.27 | 258.14 | 1.00% |
NASDAQ | 21,879.49 | 80.79 | 0.37% |
Nikkei 225 | 43,837.67 | 378.38 | 0.87% |
NZX 50 Index | 13,276.24 | 22.51 | 0.17% |
S&P 500 | 6,512.61 | 17.46 | 0.27% |
S&P/ASX 200 | 8,830.40 | 40.00 | 0.46% |
SSE Composite Index | 3,812.22 | 4.93 | 0.13% |